Ask AI
ProCE Banner Activity

DLBCL: Biology, Prognosis, and Selection of Initial Therapy

Slideset Download
Download these slides from a live symposium at ASH 2022 to gain more insight into the biology, prognosis, and selection of initial therapy for patients with DLBCL.

Released: December 12, 2022

Share

Provided by

Provided by Clinical Care Options, LLC.
ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Genmab US Inc and AbbVie

Karyopharm Therapeutics Inc.

Regeneron Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

Laurie H. Sehn, MD, MPH

Chair, Lymphoma Tumor Group
BC Cancer
Clinical Professor
University of British Columbia
Vancouver, BC, Canada